Download by
Scanning QR Code
No Stock Yet
SVB Securities Keeps Their Buy Rating on HilleVax, Inc (HLVX)
HilleVax Reports Results From Ongoing Phase 2b Trial of HIL-214
HilleVax Announces Immunogenicity Results For Run-In Cohort Of NEST-IN1 Phase 2b Clinical Trial Of HIL-214 Norovirus Vaccine Candidate
HilleVax, Inc. (NASDAQ:HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported results from a prespecified immunogenicity analysis of
Franklin Resources Inc. Purchases New Position in HilleVax, Inc. (NASDAQ:HLVX)
Franklin Resources Inc. purchased a new stake in shares of HilleVax, Inc. (NASDAQ:HLVX – Get Rating) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securiti
Alps Advisors Inc. Acquires Shares of 19,825 HilleVax, Inc. (NASDAQ:HLVX)
Alps Advisors Inc. acquired a new stake in HilleVax, Inc. (NASDAQ:HLVX – Get Rating) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission
HilleVax (NASDAQ:HLVX) Shares Gap Down to $21.02
HilleVax, Inc. (NASDAQ:HLVX – Get Rating) gapped down before the market opened on Wednesday . The stock had previously closed at $21.02, but opened at $20.42. HilleVax shares last traded at $20.51, w
Best Buy, Abercrombie & Fitch, Burlington Stores And Some Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Tuesday. Here are some big stocks recording gains in today's session. Aenza S.A.A. (NYSE:AENZ) shares surged 42.7% to $3.4999
SVB Securities Reaffirms Their Buy Rating on HilleVax, Inc (HLVX)
HilleVax, Inc. (NASDAQ:HLVX) Short Interest Update
HilleVax, Inc. (NASDAQ:HLVX – Get Rating) was the target of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 737,700 shares, an
HilleVax Reports Q3 Results
Loading...
No Stock Yet